Ethyl 6-oxo-2-(trifluoromethyl)-1,4,5,6-tetrahydro-3-pyridinecarboxylate, 95.0%, 1g

4-Chloro-2-methyl-6,7-dihydro-5H-cyclopenta[4,5]thieno[2,3-d]pyrimidine, 97.0%, 250mg

5-Amino-2-chloro-N,N-diethylbenzene-1-sulfonamide, 97%, 100mg

Thiophene-2,5-dicarboxylic acid monomethyl ester, 95.0%, 5g

5-Bromo-2-methyl-1H-benzo[d]imidazole, 95.0%, 1g

Methyl 1-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-enecarboxylate, 95%, 5g

2,5-Dihydroxybenzoic Acid [Matrix for MALDI-TOF/MS]>99.0%(GC)(T)1g

1-[4-(3-methoxyphenyl)-1H-imidazol-2-yl]ethan-1-amine, 98%, 100mg

(R)-tert-Butyl 6-hydroxy-1,4-oxazepane-4-carboxylate, 95.0%, 250mg

2,3-Difluoro-4-methoxyphenylacetonitrile, 1g

3-Ethyl-1-benzofuran-2-carboxylic acid, 95%, 5g

1-Propyl-1H-benzimidazole-2-sulfonic acid, 95.0%, 2.5g

5-Amino-2-(trifluoromethyl)benzimidazole, 95.0%, 1g